These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28884590)

  • 1. Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetes.
    Gonai M; Shigehisa A; Kigawa I; Kurasaki K; Chonan O; Matsuki T; Yoshida Y; Aida M; Hamano K; Terauchi Y
    Benef Microbes; 2017 Oct; 8(5):705-716. PubMed ID: 28884590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress.
    Wilms E; An R; Smolinska A; Stevens Y; Weseler AR; Elizalde M; Drittij MJ; Ioannou A; van Schooten FJ; Smidt H; Masclee AAM; Zoetendal EG; Jonkers DMAE
    Clin Nutr; 2021 May; 40(5):3019-3031. PubMed ID: 33509667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
    Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
    Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
    Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE
    Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
    Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
    Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut.
    Arnold JW; Roach J; Fabela S; Moorfield E; Ding S; Blue E; Dagher S; Magness S; Tamayo R; Bruno-Barcena JM; Azcarate-Peril MA
    Microbiome; 2021 Jan; 9(1):31. PubMed ID: 33509277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment.
    Ladirat SE; Schoterman MH; Rahaoui H; Mars M; Schuren FH; Gruppen H; Nauta A; Schols HA
    Br J Nutr; 2014 Aug; 112(4):536-46. PubMed ID: 24925303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons.
    Vulevic J; Juric A; Walton GE; Claus SP; Tzortzis G; Toward RE; Gibson GR
    Br J Nutr; 2015 Aug; 114(4):586-95. PubMed ID: 26218845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption].
    Luo YM; Liu FT; Chen MX; Tang WL; Yang YL; Tan XL; Zhou HW
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):251-260. PubMed ID: 29643029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome.
    Monteagudo-Mera A; Arthur JC; Jobin C; Keku T; Bruno-Barcena JM; Azcarate-Peril MA
    Benef Microbes; 2016; 7(2):247-64. PubMed ID: 26839072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Combined Prebiotic Galacto-Oligosaccharides and
    Beteri B; Barone M; Turroni S; Brigidi P; Tzortzis G; Vulevic J; Sekulic K; Motei DE; Costabile A
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters.
    Grimaldi R; Swann JR; Vulevic J; Gibson GR; Costabile A
    Br J Nutr; 2016 Aug; 116(3):480-6. PubMed ID: 27267934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
    Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
    Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
    Ho J; Reimer RA; Doulla M; Huang C
    Trials; 2016 Jul; 17(1):347. PubMed ID: 27456494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population.
    Liu F; Li P; Chen M; Luo Y; Prabhakar M; Zheng H; He Y; Qi Q; Long H; Zhang Y; Sheng H; Zhou H
    Sci Rep; 2017 Sep; 7(1):11789. PubMed ID: 28924143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis.
    Yang XD; Wang LK; Wu HY; Jiao L
    BMC Anesthesiol; 2018 Nov; 18(1):177. PubMed ID: 30497394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The piglet as a model for studying dietary components in infant diets: effects of galacto-oligosaccharides on intestinal functions.
    Alizadeh A; Akbari P; Difilippo E; Schols HA; Ulfman LH; Schoterman MH; Garssen J; Fink-Gremmels J; Braber S
    Br J Nutr; 2016 Feb; 115(4):605-18. PubMed ID: 26653138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice.
    Cheng W; Lu J; Lin W; Wei X; Li H; Zhao X; Jiang A; Yuan J
    Food Funct; 2018 Mar; 9(3):1612-1620. PubMed ID: 29465126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
    World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial.
    Schoemaker MH; Hageman JHJ; Ten Haaf D; Hartog A; Scholtens PAMJ; Boekhorst J; Nauta A; Bos R
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.